Stereotaxis launches robotic heart arrhythmia program at Klinikum Fürth in Germany; leading in surgical robotics.
On February 9, 2026, Stereotaxis revealed the introduction of a new robotic electrophysiology initiative at Klinikum Fürth in Fürth, Germany. As a groundbreaking company renowned for its surgical robotics in minimally invasive endovascular procedures, Stereotaxis operates on the NYSE under the ticker symbol STXS.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments